Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study-Reference-Cited by-同舟云学术

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study

Published:2006-10 Issue:2 Volume:135 Page:174-183
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Berenson James R.,Boccia Ralph,Siegel David,Bozdech Marek,Bessudo Alberto,Stadtmauer Edward,Talisman Pomeroy J.,Steis Ronald,Flam Marshall,Lutzky Jose,Jilani Syed,Volk Joseph,Wong Siu-Fun,Moss Robert,Patel Ravi,Ferretti Delina,Russell Kit,Louie Robert,Yeh Howard S.,Swift Regina A.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06280.x/fullpdf

Reference53 articles.

1. Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies

2. A Prospective, Open-Label Safety and Efficacy Study of Combination Treatment with Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients with Relapsed or Refractory Multiple Myeloma

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy;Clinical and Translational Oncology;2024-09-11

2. Modulation of Different Signaling Pathways in Liver Cancer by Arsenic Trioxide;Arsenic Toxicity Remediation: Biotechnological Approaches;2023

3. Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis;Oxidative Medicine and Cellular Longevity;2022-09-19

4. Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of Cardiotoxicity;Drug Safety;2022-01-13

5. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome;PharmaNutrition;2020-06